Alkami Technology (ALKT) director purchases 5,500 shares in open market trade

Rhea-AI Filing Summary

Alkami Technology director Joseph P. Payne bought 5,500 shares of common stock in an open-market transaction. He paid $18.225 per share on this purchase. After the transaction, Payne directly owns 26,628 Alkami Technology common shares, according to the Form 4 filing.

Insights

Equity ownership and governance analyst

Alkami director makes a modest open-market share purchase, signaling increased personal exposure.

Director Joseph P. Payne acquired 5,500 shares of Alkami Technology common stock in an open-market transaction at $18.225 per share. Open-market purchases typically reflect a deliberate decision to commit personal capital at the prevailing trading price.

Following this trade, Payne directly owns 26,628 common shares. This filing shows a net-buy pattern with no accompanying derivative exercises or sales, suggesting a straightforward increase in equity holdings rather than a compensation-related or tax-withholding event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Joseph P.

(Last) (First) (Middle)

C/O ALKAMI TECHNOLOGY, INC.

5601 GRANITE PARKWAY, SUITE 120

(Street)

PLANO TX 75024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		P		5,500	A	$18.225	26,628	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/Douglas A. Linebarger, as Attorney-in-Fact for Joseph P. Payne	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alkami Technology (ALKT) director Joseph P. Payne report in this Form 4 filing?

Director Joseph P. Payne reported buying 5,500 shares of Alkami Technology common stock. The shares were purchased in an open-market transaction at $18.225 per share, and the filing shows his direct ownership increased to 26,628 common shares after the transaction.

How many Alkami Technology (ALKT) shares did Joseph P. Payne buy and at what price?

Joseph P. Payne bought 5,500 Alkami Technology common shares at $18.225 per share. This open-market purchase reflects a direct cash investment at the prevailing market price, increasing his total directly held stake to 26,628 common shares as disclosed in the Form 4.

What is Joseph P. Payne’s total Alkami Technology (ALKT) shareholding after this transaction?

After the reported transaction, Joseph P. Payne directly owns 26,628 Alkami Technology common shares. This total reflects his position following the open-market purchase of 5,500 shares at $18.225 per share, with the filing indicating direct, not indirect, ownership of these shares.

Was the Alkami Technology (ALKT) Form 4 transaction a buy or a sell?

The Form 4 shows a buy transaction, specifically an open-market purchase coded as “P.” Joseph P. Payne acquired 5,500 common shares at $18.225 each, and no sales, derivative exercises, gifts, or tax-withholding dispositions were reported in this filing.

Did Joseph P. Payne use derivatives or options in this Alkami Technology (ALKT) trade?

No, the reported transaction involves only common stock, not derivatives or options. The Form 4 lists a single non-derivative open-market purchase of 5,500 common shares, and the derivative position summary is empty, indicating no derivative exercises in this filing.